Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
V0191 for mild cognitive impairment of the Alzheimer type
2007-001975-12Phase 2Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Mild Cognitive Impairment (MCI) and confusion comparing V0191 with Placebo (2 arms). Primary endpoints: Change in neuropsychological test scores at 12 weeks and Change in neuropsychological test scores at 24 weeks. Started May 2007; status: completed.
02
Drugs
deanol
03
Conditions
Mild Cognitive Impairment (MCI)confusion
Beyond the preview
Go deeper on 2007-001975-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001975-12.